ArticleFrontiers in immunology2023

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.

Katherine E R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.